Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its first quarter 2026 ...
New Scientist on MSNOpinion
Is an AI version of Mark Zuckerberg – or any boss – a good plan?
Feedback has learned that, according to reports, Meta is building an AI version of Mark Zuckerberg to interact with staff.
AI has brought rapid cultural change but one thing remains the same – artists can help us grapple with the tough questions.
Discover 100 facts that will mess with your brain! Explore mind-bending truths about your body, animals, and history. Prepare ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results